Status:
COMPLETED
Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Fatty Liver
Diabetes Mellitus, Type 2
Eligibility:
All Genders
20-65 years
Phase:
EARLY_PHASE1
Brief Summary
The investigators want to evaluate the effects and safety of ginger in treatment of nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM).
Detailed Description
Ginger (Zingiber officinale Roscoe) has been cultivated for medicinal and culinary purposes for at least two millennia. It contains several hundred valuable compounds and new constituents are still be...
Eligibility Criteria
Inclusion
- Controlled type 2 diabetes mellitus (HbA1c\<7%)
- Age: 20-65 years
- Body mass index: 18-35 kg/m2
- Serum ALT level: \>60 U/Lit. in males, \>38 U/Lit. in females
- Grade \>=2 fatty liver in liver sonography
Exclusion
- Pregnancy
- Acute or chronic liver failure
- Acute or chronic renal failure
- Autoimmune or viral hepatitis
- Wilson's disease
- Alcoholism
- Malignancy
- Hypothyroidism or hyperthyroidism
- Drug used in last three months: OCP, vitamin E, ursodeoxycholic acid, glucocorticoids.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT02289235
Start Date
May 1 2019
End Date
February 1 2020
Last Update
October 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shahid Motahhari Clinic, Shiraz University of Medical Sciences
Shiraz, Fars, Iran